Related Experiment Videos

Antiphospholipid syndrome in patients with cyanotic congenital heart disease

M Martínez-Lavín1, C Fonseca, M C Amigo

  • 1Rheumatology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico, México D.F.

Insights

Cyanotic congenital heart disease patients often experience blood clots and low platelets. This study found anticardiolipin antibodies in 3/15 patients, suggesting a link to antiphospholipid syndrome.

Area of Science:

  • Cardiology
  • Immunology
  • Hematology

Background:

  • Patients with cyanotic congenital heart disease (CCHD) have a higher risk of thrombotic events.
  • Thrombocytopenia (low platelet count) is also common in CCHD patients.
  • Antiphospholipid syndrome (APS) is characterized by autoantibodies and thrombotic events.

Purpose of the Study:

  • To investigate the prevalence of anticardiolipin antibodies (aCL) in patients with CCHD.
  • To explore a potential association between CCHD and antiphospholipid syndrome.

Main Methods:

  • Serum samples were collected from 15 patients diagnosed with CCHD.
  • Samples were tested for the presence of anticardiolipin antibodies.
  • Clinical data, including thrombotic history and VDRL test results, were reviewed.

Main Results:

  • Anticardiolipin antibodies were detected in 3 out of 15 (20%) CCHD patients.
  • All positive cases were adult females.
  • Two of the three positive patients had a history of thrombotic episodes and a false-positive Venereal Disease Research Laboratory (VDRL) test.

Conclusions:

  • Cyanotic congenital heart disease may be associated with the antiphospholipid syndrome.
  • The presence of aCL in CCHD patients warrants further investigation.
  • CCHD patients, particularly adult females with thrombotic history, may benefit from screening for antiphospholipid antibodies.

Related Concept Videos